» Articles » PMID: 38321454

The Anti-fungal Effect of Miconazole and Miconazole-loaded Chitosan Nanoparticles Gels in Diabetic Patients with Oral Candidiasis-randomized Control Clinical Trial and Microbiological Analysis

Overview
Journal BMC Oral Health
Publisher Biomed Central
Specialty Dentistry
Date 2024 Feb 6
PMID 38321454
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Oral thrush is the most common occurring fungal infection in the oral cavity in uncontrolled diabetic patients, it is treated by various antifungal drugs according to each case. This study aimed to evaluate the therapeutic effects of topical application of miconazole and miconazole-loaded chitosan nanoparticles in treatment of diabetic patients with oral candidiasis.

Methods: In this randomized controlled clinical trial. A total of 80 diabetic patients presenting with symptomatic oral candidiasis were randomly assigned into two treatment groups: miconazole and miconazole-loaded chitosan nanoparticles. The patients were treated for 28 days, and clinical assessments were conducted at baseline, 7, 14, 21 and 28 days. Clinical parameters, including signs and symptoms of oral candidiasis were evaluated and microbiological analysis was performed to determine the Candida species and assess their susceptibility to the antifungal agents. Statistical analysis was done to the categorical and numerical data using chi-square test and Kruskal Wallis test.

Results: The antifungal efficacy between the miconazole and miconazole-loaded chitosan nanoparticles (CS-MCZ) groups insignificant difference (P >  0.05) was observed. Both treatment modalities exhibited comparable effectiveness in controlling oral candidiasis symptoms and reducing Candida colonization as miconazole-loaded chitosan nanoparticles group showed a significant difference in the clinical improvement in respect of both signs and symptoms from baseline (70%) until the end of study at 28 days (5%) (P <  0.05) Moreover, miconazole-loaded chitosan nanoparticles, there was a significant reduction in the number of colonies forming units of Candida albicans from baseline until the end of the study at 28-day with P value <  0.000.

Conclusions: This randomized controlled clinical trial and microbiological analysis demonstrate that both miconazole and miconazole-loaded chitosan nanoparticles are effective in the treatment of oral candidiasis in diabetic patients with no adverse reactions.

Trial Registration: NCT06072716 with first registration first registration in 10/10/2023.

Citing Articles

Layer-by-Layer Biopolymer-Coated Deformable Liposomes-In Situ Gel: A Hybrid Strategy for Enhanced Ocular Delivery of Itraconazole: In Vitro and In Vivo Appraisal.

Badran M, Alsubaie A, Bekhit M, Alomrani A, Almomen A Gels. 2025; 11(1).

PMID: 39851990 PMC: 11765087. DOI: 10.3390/gels11010019.


Biodegradable Polymeric Nanoparticle-Based Drug Delivery Systems: Comprehensive Overview, Perspectives and Challenges.

Geszke-Moritz M, Moritz M Polymers (Basel). 2024; 16(17).

PMID: 39274168 PMC: 11397980. DOI: 10.3390/polym16172536.


Tailored Sticky Solutions: 3D-Printed Miconazole Buccal Films for Pediatric Oral Candidiasis.

Chachlioutaki K, Iordanopoulou A, Katsamenis O, Tsitsos A, Koltsakidis S, Anastasiadou P AAPS PharmSciTech. 2024; 25(7):190.

PMID: 39164432 DOI: 10.1208/s12249-024-02908-5.


The Efficacy of Hybrid Vaginal Ovules for Co-Delivery of Curcumin and Miconazole against .

Bezerra B, Y Araujo S, Alves-Junior J, Damasceno B, Oshiro-Junior J Pharmaceutics. 2024; 16(3).

PMID: 38543206 PMC: 10974232. DOI: 10.3390/pharmaceutics16030312.

References
1.
Petricca S, Celenza G, Luzi C, Cinque B, Lizzi A, Franceschini N . Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells. Int J Mol Sci. 2022; 23(10). PMC: 9140920. DOI: 10.3390/ijms23105429. View

2.
Imam S, Gilani S, Zafar A, Bin Jumah M, Alshehri S . Formulation of Miconazole-Loaded Chitosan-Carbopol Vesicular Gel: Optimization to In Vitro Characterization, Irritation, and Antifungal Assessment. Pharmaceutics. 2023; 15(2). PMC: 9959533. DOI: 10.3390/pharmaceutics15020581. View

3.
Shih P, Liao Y, Tseng Y, Deng F, Lin C . A Potential Antifungal Effect of Chitosan Against Is Mediated via the Inhibition of SAGA Complex Component Expression and the Subsequent Alteration of Cell Surface Integrity. Front Microbiol. 2019; 10:602. PMC: 6443709. DOI: 10.3389/fmicb.2019.00602. View

4.
Talapko J, Juzbasic M, Matijevic T, Pustijanac E, Bekic S, Kotris I . The Virulence Factors and Clinical Manifestations of Infection. J Fungi (Basel). 2021; 7(2). PMC: 7912069. DOI: 10.3390/jof7020079. View

5.
Quindos G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N . Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019; 24(2):e172-e180. PMC: 6441600. DOI: 10.4317/medoral.22978. View